10times
06 May 2021Ended

Acute Myeloid Leukemia AML: Utilizing Single-Cell Multi-Omics to Uncover its Evolution and Resistance Mechanisms

AboutSpeakersExhibitorsReviewsPhotos

Estimated Turnout

100 - 500
Delegates
Based on previous editions

Editions

May 2021

Frequency

Not Available
Claim event to edit details

Gene mutation-targeted therapies are a treatment option for patients with relapsed/refractory AML. The acquisition of new mutations and the emergence .. Read more of new subclones during the course of therapy can drive relapse. Rather, deciphering the mechanisms of resistance to these drugs requires the dissection of AML at a single-cell level. Mission Bio is a life sciences company that accelerates discoveries and cures in oncology by equipping researchers with the ability to measure multi-omics at single-cell resolution. Mission Bio’s multi-omics approach improves time-to-market for new therapeutics, including innovative cell and gene therapies that provide new pathways to health. Partnering with pharma and biopharma companies, Mission Bio implements proven single-cell multi-omics capabilities into discovery, translational, and clinical research efforts. Our hand-curated daily news feed and active message forums will keep you informed.

  • Followers
  • [ Users who have shown interest for this Event ]
indu.mrdc

indu.mrdc

Dentist at Manav Rachna Dental College

Faridabad, India
  • Share your Experience
  • Organizer
Logo Follow Company

Xtalks

Canada463 Total Events / 19 Upcoming Events

More Events From The Organizer

You have no contacts. Please add contacts from below or share on social media

Send to all
No Results